Source: Cellular Signalling. Unidade: ICB
Subjects: ANATOMIA, DOENÇAS CARDIOVASCULARES, SISTEMA RENINA-ANGIOTENSINA, HIPERTROFIA VENTRICULAR ESQUERDA, INFARTO DO MIOCÁRDIO, ALDOSTERONA, INFECÇÕES POR CORONAVIRUS, ANGIOTENSINA II, OLIGOPEPTÍDEOS
ABNT
LINO, Caroline Antunes; CHAVES, Maria Luiza Barreto. Beta-arrestins in the context of cardiovascular diseases: focusing on angiotensin II type 1 receptor (AT1R). Cellular Signalling, Philadelphia, v. 92, p. 1-9, 2022. Disponível em: < https://doi.org/10.1016/j.cellsig.2022.110253 > DOI: 10.1016/j.cellsig.2022.110253.APA
Lino, C. A., & Chaves, M. L. B. (2022). Beta-arrestins in the context of cardiovascular diseases: focusing on angiotensin II type 1 receptor (AT1R). Cellular Signalling, 92, 1-9. doi:10.1016/j.cellsig.2022.110253NLM
Lino CA, Chaves MLB. Beta-arrestins in the context of cardiovascular diseases: focusing on angiotensin II type 1 receptor (AT1R) [Internet]. Cellular Signalling. 2022 ; 92 1-9.Available from: https://doi.org/10.1016/j.cellsig.2022.110253Vancouver
Lino CA, Chaves MLB. Beta-arrestins in the context of cardiovascular diseases: focusing on angiotensin II type 1 receptor (AT1R) [Internet]. Cellular Signalling. 2022 ; 92 1-9.Available from: https://doi.org/10.1016/j.cellsig.2022.110253